| abstract |
The present application is a method for treating or ameliorating myocardial ischemia, acute coronary event, and myocardial reperfusion injury, wherein a therapeutically effective amount of deferiprone or a pharmaceutically acceptable thereof is provided to a patient in need thereof. The method comprising administering a salt to be prepared. The present application is a method of reducing the risk of myocardial reperfusion injury in a patient and promoting beneficial cardiac tissue remodeling, wherein a therapeutically effective amount of deferiprone or a pharmaceutically acceptable salt thereof is It also relates to a method comprising administering to a patient before perfusion treatment, during reperfusion treatment, or after reperfusion treatment. The application also includes a method of selecting a patient for treatment of a reperfusion injury and then treating the selected patient. |